New drug combo tested for hepatitis c patients who failed prior treatment
NCT ID NCT00781274
Summary
This study tested whether adding an experimental drug called MP-424 to two standard Hepatitis C medications could help patients whose previous treatments didn't work. It involved 32 adults with a specific type of Hepatitis C (Genotype 1) who had not responded to earlier therapy. The main goal was to see if this three-drug combination could clear the virus from the blood long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toranomon Hospital
Kawasaki, Takatsu-ku, Japan
Conditions
Explore the condition pages connected to this study.